Table 2 Results of the biochemical urine analysis.

From: Urinary calprotectin as a diagnostic tool for detecting significant bacteriuria

Variables

Total patients 162, (100%)

Patients with UTIs 71, (43.82%)

Patients without UTIs 91, (56.18%)

p-value*

Calprotectin in ng/ml (median, IQR)

1758.5 242.4–6260.4

3811.9 1102.5–8241.2

787.8 86.6–3253.0

 < 0.001

Calprotectin/Creatinin in ng/mg (median, IQR)

2859.9 384.3–10,414.5

4637.0 1634.8–22,820.6

887.9 109.9–5044.8

 < 0.001

Nitrites n, (%)

32 (19.75%)

22 (30.99%)

10 (10.99%)

0.002

Pyuria n, (%)

103 (63.58%)

59 (83.10%)

44 (48.35%)

 < 0.001

Pyuria 25/µl n, (%)

25 (15.43%)

13 (18.31%)

12 (13.19%)

0.372

Pyuria 75/µl n, (%)

9 (5.56%)

3 (4.23%)

6 (6.59%)

0.515

Pyuria 100/µl n, (%)

9 (5.56%)

4 (5.63%)

5 (5.49%)

0.969

Pyuria 500/µl n, (%)

60 (37.04%)

39 (54.93%)

21 (23.08%)

 < 0.001

Hematuria

87 (53.70%)

43 (60.56%)

44 (48.35%)

0.123

Proteinuria in Urinanalysis n, (%)

64 (39.51%)

39 (54.93%)

25 (27.47%)

 < 0.001

PCR in mg/g Creatinin (median, IQR)

139 74.7–299.5

222 99.3–399.0

89.90 62.9–203.5

 < 0.001

ACR in mg/g Creatinin (median, IQR)

29.5 5.0–97.8

64.0 7.7–143.0

11.5 3.8–54.7

 < 0.001

  1. UTIs urinary tract infections, PCR Protein/Creatinin ratio, ACR Albumin/Creatinin ration, IQR interquartile range.
  2. *p-value between patients with and without UTIs from Mann–Whitney-U-Test.